Premium-Grade Research Peptides You Can Trust!!
When the peptide Semax is injected, it is delivered to the pituitary gland to increase the production of the happy hormones, serotonin and dopamine.
It also increases BDNF (Brain Derived Neurotrophic Factor) to aid in learning and memory and GABA (Gamma-aminobutyric Acid) to calm the brain.
It is often combined with Selank for additional improvements to stress responses, anxiety levels, and calmness.
Enhanced purity standards with third-party verification and GMP certification.
Recommended Dose: Inject 5 units (500mcg) daily.
Administration: Subcutaneous injection
Timing: On an empty stomach, at least 1 hour before/after eating..
Cycle: Best results occur when taken consistently for 4-12 weeks.
99% Purity tested via HPLC methods.
Store in a cool and dry place away from children.
1 vial, all supplies included
2 vials, all supplies included
Using our dosage recommendations listed above, 1 vial will provide 40 500mcg (5 unit) doses, lasting 5.71 weeks.Due to the overage of peptide solution in the vial, we provide extra syringes and wipes to ensure the entirety of the vial can be used, if desired. However, only 28 doses are needed for the 4 week protocol.
Using our dosage recommendations listed above, 3 vials will provide 120 500mcg (5 unit) doses, lasting 17.14 weeks.Due to the overage of peptide solution in the vial, we provide extra syringes and wipes to ensure the entirety of the vials can be used, if desired. However, only 84 doses are needed for the 12 week protocol.
Published in 2021 in Neuropeptides, this preclinical study showed that Semax (administered intraperitoneally) countered long-term anxiety, learning deficits, and monoamine imbalances caused by neonatal SSRI exposure in rats, demonstrating its potential to mitigate developmental neurochemical disruptions.
Read StudyPublished in 2020 in Bulletin of Experimental Biology and Medicine, this human resting-state fMRI study in healthy participants found that injected Semax rapidly altered functional connectivity in anxiety and executive function brain regions (e.g., amygdala and DLPFC) within 5–20 minutes, supporting its fast-acting nootropic and anxiolytic mechanisms.
Read StudyPublished in 2022 in ACS Chemical Neuroscience, this in vitro study revealed Semax's ability to prevent Cu2+-induced Aβ aggregation and toxicity (relevant to Alzheimer's models), with protective anti-aggregating effects, suggesting neuroprotective potential against metal-induced neurodegeneration.
Read Study



Based on 0 reviews
You must be logged in to post a review.
There are no reviews yet.
Reviews